Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2012 Dec 28;7(2):59–76. [Article in German] doi: 10.1007/s11812-012-0051-1

Akutes Leberversagen

Katharina Staufer 1, Michael Trauner 1, Valentin Fuhrmann 1,✉
PMCID: PMC7101669  PMID: 32288850

The content is available as a PDF (796.5 KB).

Literatur

  • 1.Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98. [PubMed] [Google Scholar]
  • 2.Lee WM, Squires RH Jr., Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008 Apr;47(4):1401–15 (Clinical Conference Research Support, N.I.H., Extramural). [DOI] [PMC free article] [PubMed]
  • 3.O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439–45. doi: 10.1016/0016-5085(89)90081-4. [DOI] [PubMed] [Google Scholar]
  • 4.O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342(8866):273–5. doi: 10.1016/0140-6736(93)91818-7. [DOI] [PubMed] [Google Scholar]
  • 5.Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41(5):1179–97. doi: 10.1002/hep.20703. [DOI] [PubMed] [Google Scholar]
  • 6.Ichai P, Samuel D. Epidemiology of liver failure. Clin Res Hepatol Gastroenterol. 2011;35(10):610–7. doi: 10.1016/j.clinre.2011.03.010. [DOI] [PubMed] [Google Scholar]
  • 7.Daniels D GS, Wasley A. Centers for disease control and prevention. Surveillance for acute viral hepatitis – United States. 2007;58:1–27. [PubMed] [Google Scholar]
  • 8.Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006;28:101–11. doi: 10.1093/epirev/mxj012. [DOI] [PubMed] [Google Scholar]
  • 9.Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology. 2006;44(6):1589–97. doi: 10.1002/hep.21439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Khuroo MS, Kamili S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat. 2009;16(7):519–23. doi: 10.1111/j.1365-2893.2009.01101.x. [DOI] [PubMed] [Google Scholar]
  • 11.Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis. J Viral Hepat. 2008;15(2):89–102. doi: 10.1111/j.1365-2893.2007.00902.x. [DOI] [PubMed] [Google Scholar]
  • 12.Yeo W, Zee B, Zhong S, Chan PK, Wong WL, Ho WM. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer. 2004;90(7):1306–11. doi: 10.1038/sj.bjc.6601699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J. 1966;2(5512):497–9. doi: 10.1136/bmj.2.5512.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Strnad P, Zhou Q, Hanada S, Lazzeroni LC, Zhong BH, So P. Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology. 2010;139(3):828–35. doi: 10.1053/j.gastro.2010.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Prescott LF. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs. 1983;25(3):290–314. doi: 10.2165/00003495-198325030-00002. [DOI] [PubMed] [Google Scholar]
  • 16.Broussard CN, Aggarwal A, Lacey SR, Post AB, Gramlich T, Henderson JM. Mushroom poisoning–from diarrhea to liver transplantation. Am J Gastroenterol. 2001;96(11):3195–8. doi: 10.1111/j.1572-0241.2001.05283.x. [DOI] [PubMed] [Google Scholar]
  • 17.Escudie L, Francoz C, Vinel JP, Moucari R, Cournot M, Paradis V. Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol. 2007;46(3):466–73. doi: 10.1016/j.jhep.2006.10.013. [DOI] [PubMed] [Google Scholar]
  • 18.Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512–21. doi: 10.1053/j.gastro.2005.05.006. [DOI] [PubMed] [Google Scholar]
  • 19.Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36(2):451–5. doi: 10.1053/jhep.2002.34857. [DOI] [PubMed] [Google Scholar]
  • 20.Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42(2):481–9. doi: 10.1002/hep.20800. [DOI] [PubMed] [Google Scholar]
  • 21.Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis. 2009;29(4):400–11. doi: 10.1055/s-0029-1240009. [DOI] [PubMed] [Google Scholar]
  • 22.Lucena MI, Andrade RJ, Martinez C, Ulzurrun E, Garcia-Martin E, Borraz Y. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology. 2008;48(2):588–96. doi: 10.1002/hep.22370. [DOI] [PubMed] [Google Scholar]
  • 23.Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis – epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122(5–6):129–39. doi: 10.1007/s00508-010-1357-6. [DOI] [PubMed] [Google Scholar]
  • 24.Taylor BJ, Kjaergaard J, Snyder EM, Olson TP, Johnson BD. Pulmonary capillary recruitment in response to hypoxia in healthy humans: a possible role for hypoxic pulmonary venoconstriction? Respir Physiol Neurobiol. 2011 Jul 31;177(2):98–107 (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t). [DOI] [PMC free article] [PubMed]
  • 25.Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom. Semin Liver Dis. 2003;23(3):227–37. doi: 10.1055/s-2003-42640. [DOI] [PubMed] [Google Scholar]
  • 26.Wei G, Kalaitzakis E, Bergquist A, Bjornsson E. Long-term follow-up of patients with acute liver failure of indeterminate aetiology. Scand J Gastroenterol. 2008;43(8):984–91. doi: 10.1080/00365520801965399. [DOI] [PubMed] [Google Scholar]
  • 27.Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376(9736):190–201. doi: 10.1016/S0140-6736(10)60274-7. [DOI] [PubMed] [Google Scholar]
  • 28.Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14(Suppl 2):S67–79. doi: 10.1002/lt.21612. [DOI] [PubMed] [Google Scholar]
  • 29.Albrecht J, Zielinska M, Norenberg MD. Glutamine as a mediator of ammonia neurotoxicity: a critical appraisal. Biochem Pharmacol. 2010;80(9):1303–8. doi: 10.1016/j.bcp.2010.07.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46(6):1844–52. doi: 10.1002/hep.21838. [DOI] [PubMed] [Google Scholar]
  • 31.Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology. 1977;72(4 Pt 1):573–83. [PubMed] [Google Scholar]
  • 32.Parsons-Smith BG, Summerskill WH, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet. 1957;273(7001):867–71. doi: 10.1016/S0140-6736(57)90005-3. [DOI] [PubMed] [Google Scholar]
  • 33.Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol. 2004 Feb;40(2):192–7 (Review). [DOI] [PubMed]
  • 34.Lee WM. Acute liver failure. N Engl J Med. 1993;329(25):1862–72. doi: 10.1056/NEJM199312163292508. [DOI] [PubMed] [Google Scholar]
  • 35.Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45(3):789–96. doi: 10.1002/hep.21503. [DOI] [PubMed] [Google Scholar]
  • 36.Mitchell I, Bihari D, Chang R, Wendon J, Williams R. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med. 1998;26(2):279–84. doi: 10.1097/00003246-199802000-00026. [DOI] [PubMed] [Google Scholar]
  • 37.Rutherford A, Davern T, Hay JE, Murray NG, Hassanein T, Lee WM. Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol. 2006;4(12):1544–9. doi: 10.1016/j.cgh.2006.07.014. [DOI] [PubMed] [Google Scholar]
  • 38.Schmidt LE, Larsen FS. Blood lactate as a prognostic marker in acetaminophen-induced acute liver failure. Hepatology. 2003;37(5):1199–201. doi: 10.1002/hep.510370530. [DOI] [PubMed] [Google Scholar]
  • 39.Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology. 2002;36(3):659–65. doi: 10.1053/jhep.2002.35069. [DOI] [PubMed] [Google Scholar]
  • 40.Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856–64. doi: 10.1053/j.gastro.2009.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Prescott L. Paracetamol (acetaminophen): a critical bibliographic review. London: Taylor and Francis; 1996. [Google Scholar]
  • 42.Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35(11):2498–508. doi: 10.1097/01.CCM.0000287592.94554.5F. [DOI] [PubMed] [Google Scholar]
  • 43.Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975;55(6):871–6. [PubMed] [Google Scholar]
  • 44.Lee WM, Stravitz RT, Larson A. Introduction to the revised AASLD position paper on acute liver failure 2011. Hepatology. 2011 Dec 27. [DOI] [PMC free article] [PubMed]
  • 45.Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology. 2007;45(1):97–101. doi: 10.1002/hep.21486. [DOI] [PubMed] [Google Scholar]
  • 46.Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat. 2006;13(4):256–63. doi: 10.1111/j.1365-2893.2005.00695.x. [DOI] [PubMed] [Google Scholar]
  • 47.Jochum C, Gieseler RK, Gawlista I, Fiedler A, Manka P, Saner FH. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion. 2009;80(4):235–40. doi: 10.1159/000236009. [DOI] [PubMed] [Google Scholar]
  • 48.Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011;53(3):774–80. doi: 10.1002/hep.24109. [DOI] [PubMed] [Google Scholar]
  • 49.Ichai P, Duclos-Vallee JC, Guettier C, Hamida SB, Antonini T, Delvart V. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver transpl. 2007;13(7):996–1003. doi: 10.1002/lt.21036. [DOI] [PubMed] [Google Scholar]
  • 50.Czaja AJ. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation. Liver transpl. 2007;13(7):953–5. doi: 10.1002/lt.21088. [DOI] [PubMed] [Google Scholar]
  • 51.Potts JR, Verma S. Optimizing management in autoimmune hepatitis with liver failure at initial presentation. World J Gastroenterol: WJG. 2011 Apr 28;17(16):2070–5 (Editorial Review). [DOI] [PMC free article] [PubMed]
  • 52.Peters DJ, Greene WH, Ruggiero F, McGarrity TJ. Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy. Dig Dis Sci. 2000;45(12):2399–404. doi: 10.1023/A:1005699210816. [DOI] [PubMed] [Google Scholar]
  • 53.Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med. 1991;20(10):1058–63. doi: 10.1016/S0196-0644(05)81352-6. [DOI] [PubMed] [Google Scholar]
  • 54.Floersheim GL, Eberhard M, Tschumi P, Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978;46(2):455–62. doi: 10.1016/0041-008X(78)90091-1. [DOI] [PubMed] [Google Scholar]
  • 55.Hruby K, Csomos G, Fuhrmann M, Thaler H. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol. 1983;2(2):183–95. doi: 10.1177/096032718300200203. [DOI] [PubMed] [Google Scholar]
  • 56.Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36(2):479–97. doi: 10.1053/jhep.2002.34944. [DOI] [PubMed] [Google Scholar]
  • 57.Maclayton DO, Eaton-Maxwell A. Rifaximin for treatment of hepatic encephalopathy. Ann Pharmacother. 2009;43(1):77–84. doi: 10.1345/aph.1K436. [DOI] [PubMed] [Google Scholar]
  • 58.Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136(7):2159–68. doi: 10.1053/j.gastro.2009.02.050. [DOI] [PubMed] [Google Scholar]
  • 59.Larsen FS, Wendon J. Prevention and management of brain edema in patients with acute liver failure. Liver transpl. 2008;14(Suppl 2):S90–6. doi: 10.1002/lt.21643. [DOI] [PubMed] [Google Scholar]
  • 60.Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver transpl. 2005;11(12):1581–9. doi: 10.1002/lt.20625. [DOI] [PubMed] [Google Scholar]
  • 61.Jalan R, Rose C. Hypothermia in acute liver failure. Metab Brain Dis. 2004;19(3–4):215–21. doi: 10.1023/B:MEBR.0000043971.72170.a2. [DOI] [PubMed] [Google Scholar]
  • 62.Stravitz RT, Larsen FS. Therapeutic hypothermia for acute liver failure. Crit Care Med. 2009;37(7 Suppl):S258–64. doi: 10.1097/CCM.0b013e3181aa5fb8. [DOI] [PubMed] [Google Scholar]
  • 63.Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology. 1994;19(6):1407–13. doi: 10.1002/hep.1840190614. [DOI] [PubMed] [Google Scholar]
  • 64.Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125(3):755–64. doi: 10.1016/S0016-5085(03)01051-5. [DOI] [PubMed] [Google Scholar]
  • 65.Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver international: official journal of the International Association for the Study of the Liver. Apr. 2003;23(2):71–7. doi: 10.1034/j.1600-0676.2003.00813.x. [DOI] [PubMed] [Google Scholar]
  • 66.Shawcross DL, Davies NA, Mookerjee RP, Hayes PC, Williams R, Lee A. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology. 2004;39(2):471–5. doi: 10.1002/hep.20044. [DOI] [PubMed] [Google Scholar]
  • 67.Davenport A, Will EJ, Davison AM. Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant. 1990;5(3):192–8. doi: 10.1093/ndt/5.3.192. [DOI] [PubMed] [Google Scholar]
  • 68.Mehta RL. Continuous renal replacement therapy in the critically ill patient. Kidney Int. 2005 Feb;67(2):781–95 (Clinical Conference Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, P.H.S.). [DOI] [PubMed]
  • 69.van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67. doi: 10.1056/NEJMoa011300. [DOI] [PubMed] [Google Scholar]
  • 70.Munoz SJ. Nutritional therapies in liver disease. Semin Liver Dis. 1991;11(4):278–91. doi: 10.1055/s-2008-1040446. [DOI] [PubMed] [Google Scholar]
  • 71.Devlin J, Wendon J, Heaton N, Tan KC, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology. 1995;21(4):1018–24. doi: 10.1002/hep.1840210420. [DOI] [PubMed] [Google Scholar]
  • 72.Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation. 2006;81(2):195–201. doi: 10.1097/01.tp.0000188149.90975.63. [DOI] [PubMed] [Google Scholar]
  • 73.Steadman RH, Van Rensburg A, Kramer DJ. Transplantation for acute liver failure: perioperative management. Curr Opin Organ Transplant. 2010;15(3):368–73. doi: 10.1097/MOT.0b013e32833982dd. [DOI] [PubMed] [Google Scholar]
  • 74.Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239(5):660–7. doi: 10.1097/01.sla.0000124298.74199.e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Saliba F CC, Durand F. Randomized controlled multicenter trial evaluating the efficacy and saftey of albumin dialysis with MARS® in patients with fulminant and subfulminant hepatic failure. Hepatology. 2008;48:377A. doi: 10.1016/S0168-8278(08)61005-3. [DOI] [Google Scholar]
  • 76.Larsen FS SL, Wendon J. Liver assisting with high-volume plasma exchange in patients with acute liver failure. Hepatology. 2010;52:A114. doi: 10.1016/j.jhep.2016.05.033. [DOI] [PubMed] [Google Scholar]

Articles from Wiener Klinische Wochenschrift. Education are provided here courtesy of Nature Publishing Group

RESOURCES